Vivos Therapeutics News

Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 15 12:57 ET

Vivos Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jul 30 06:21 ET

Vivos Therapeutics | 8-K: Current report

Jul 10 08:04 ET

Vivos Therapeutics | 8-K: Current report

Jun 25 16:36 ET

Vivos Therapeutics | 8-K: Current report

Jun 14 16:21 ET

Vivos Therapeutics | 8-K: Current report

May 17 16:50 ET

Vivos Therapeutics | 8-K: Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 15 14:55 ET

Vivos Therapeutics | 8-K: Current report

May 6 12:59 ET

Vivos Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 22 12:58 ET

Vivos Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 9 12:46 ET

Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 29 12:51 ET

Vivos Therapeutics | 8-K: Current report

Feb 15 08:57 ET

Vivos Therapeutics | 8-K: Current report

Nov 30, 2023 16:05 ET

Vivos Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 30, 2023 16:03 ET

Vivos Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Nov 22, 2023 16:46 ET

Vivos Therapeutics | 8-K: Current report

Nov 2, 2023 17:10 ET

Vivos Therapeutics | 8-K: Current report

Oct 27, 2023 16:15 ET

Vivos Therapeutics | 8-K: Current report

Sep 25, 2023 09:00 ET

Vivos Therapeutics | 8-K: Current report

Sep 21, 2023 17:10 ET

Vivos Therapeutics | DEFA14A: Others

Sep 14, 2023 16:38 ET